永太科技(002326.SZ)子公司收到利丙双卡因乳膏药品注册证书

Core Viewpoint - Yongtai Technology (002326.SZ) announced that its wholly-owned subsidiary, Binhai Meikang Pharmaceutical Co., Ltd., has recently received the drug registration certificate for Lidocaine and Prilocaine Cream from the National Medical Products Administration [1] Group 1: Product Approval - The drug registration certificate pertains to a compound formulation of Lidocaine and Prilocaine, intended for local anesthesia in specific skin conditions [1] - Indications for the use of the cream include: 1. Needle punctures, such as catheter insertion or blood sampling; 2. Superficial surgical procedures, such as mucosal anesthesia before superficial surgery or infiltration anesthesia; and cleaning/debridement of leg ulcers [1]